title: Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers.
authors: David H
authors: DH
authors: Dreyfus
authors: Chang Rim
authors: CR
authors: Na
authors: Christopher C
authors: CC
authors: Randolph
authors: Denise
authors: D
authors: Kearney
authors: Christina
authors: C
authors: Price
authors: David
authors: D
authors: Podell
mesh_terms: D000328:Adult; D000799:Angioedema / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D016736:Antiphospholipid Syndrome / Q000150:complications*; D001323:Autoantibodies / Q000097:blood; D050718:Complement C1 Inhibitor Protein / Q000276:immunology*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008212:Lymphocyte Depletion / Q000379:methods; D015166:Monitoring, Immunologic; D009157:Myasthenia Gravis / Q000150:complications*; D012074:Remission Induction; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D050718:Complement C1 Inhibitor Protein; D007155:Immunologic Factors; D000069283:Rituximab